Mark Corrigan, Director at Nabriva Therapeutics plc (NBRV), sold 10,297 shares at $0.19 ($2K) on 2022-08-02, disclosed to the SEC on 2022-08-04.
Open-market sale of $2k NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CBST | SELL | 2013-05-29 | $764K | — | Filing → |
| ZLCS | SELL | 2013-01-17 | $87K | — | Filing → |
| CBST | SELL | 2012-07-26 | $410K | — | Filing → |